The examination of predictive factors and prognosis in nonalcoholic steatohepatitis

The examination of predictive factors and prognosis in nonalcoholic steatohepatitis - The examination of predictive factors and prognosis in NASH

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000030222

Enrollment

400

Registered

2017-12-01

Start date

2017-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nonalcoholic steatohepatitis (NASH) Nonalcoholic fatty liver disease (NAFLD)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Male and female over twenty years of age Biopsy-proven NAFLD patients

Exclusion criteria

Exclusion criteria: Patients with pregnancy and lactation Patients with poor condition Persons judged inappropriate for this study

Design outcomes

Primary

Measure	Time frame
Investigate the associated factors for NASH Explore the predictive factors with prognosis of NAFLD	—

Secondary

Measure	Time frame
Identify the associated factors with histological fibrosis in the liver Identify the associated factors with histological fat droplets in the liver Identify the associated factors with histological inflammation in the liver Identify the associated factors with the severity of fibrosis and steatosis in the liver assessed by the ultrasonography Explore the predictive factors for progression of fibrosis in the liver Explore the predictive factors for onset of complication of liver Explore the predictive factors for onset of metabolic diseases Explore the predictive factors for onset of atherosclerotic diseases	—

Measure

Time frame

Identify the associated factors with histological fibrosis in the liver Identify the associated factors with histological fat droplets in the liver Identify the associated factors with histological inflammation in the liver Identify the associated factors with the severity of fibrosis and steatosis in the liver assessed by the ultrasonography Explore the predictive factors for progression of fibrosis in the liver Explore the predictive factors for onset of complication of liver Explore the predictive factors for onset of metabolic diseases Explore the predictive factors for onset of atherosclerotic diseases

—

Countries

Japan

Contacts

Public ContactTeruki Miyake

Ehime University Graduate School of Medicine Department of Gastroenterology and Metabology

teruki-ygc@umin.ac.jp+81899605308

Outcome results